Einzelansicht Rollinger

[Back]

Univ.-Prof. Mag. Dr. Judith Maria Rollinger

T: +43-1-4277-55255

judith.rollinger@univie.ac.at

Winter term 2025

251032 VO Pharmakognosie (biogene Arzneimittel, med. Aspekte)

321001 VO Steop Einführung in die pharmazeutischen Wissenschaften - B1

321036 PR Drogenanalyse - B19 - (5 Kurse)

322001 VO (Bio)pharma. mit Wirkung auf metabol. Störungen & eingeschr. Organ- und Systemfunktionen - M1

322002 VO Antiinfektiva, Antineoplastika und (Bio)pharmazeutika mit Wirkung auf das Immunsystem - M2

322028 VU Ausgewählte Kapitel aus der pharmakognostischen Forschung - M13

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1

323002 UE Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1

580003 SE SE Journal Club: phytochemistry and bioactive natural products

580007 SE SE Academic training and discussion in Pharmacognosy - for doctoral students

Summer term 2025

321036 PR Drogenanalyse - B19 - (5 Kurse)

322005 VO (Bio)pharmazeutika mit Wirkung auf das Herz-Kreislauf System - M4

322006 VO (Bio)pharmazeutika mit Wirkung auf das Nervensystem - M5

322028 VU Ausgewählte Kapitel aus der pharmakognostischen Forschung - M13

322563 VU Phytotherapy: from bench to bedside - M14 - (incl. Exkursion)

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1

323002 UE Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1

323007 UE Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6 - (2 Courses)

580001 SE Journal Club: phytochemistry and bioactive natural products

580005 VU Academic training and discussion in Pharmacognosy - for doctoral students

Winter term 2024

251032 VO Pharmakognosie (biogene Arzneimittel, med. Aspekte)

321001 VO Steop Einführung in die pharmazeutischen Wissenschaften - B1

321036 PR Drogenanalyse - B19 - (5 Kurse)

322001 VO (Bio)pharma. mit Wirkung auf metabol. Störungen & eingeschr. Organ- und Systemfunktionen - M1

322002 VO Antiinfektiva, Antineoplastika und (Bio)pharmazeutika mit Wirkung auf das Immunsystem - M2

322028 VU Ausgewählte Kapitel aus der pharmakognostischen Forschung - M13

322061 VU Pharmakobotanische Exkursion nach La Gamba/Costa Rica - M14

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1

323002 UE Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1

580003 SE SE Journal Club: phytochemistry and bioactive natural products

580007 SE SE Academic training and discussion in Pharmacognosy - for doctoral students

Grienke U, Richter M, Walther E, Hoffmann A, Kirchmair J, Makarov V et al. Discovery of prenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae. Scientific Reports. 2016 Jun 3;6:27156. doi: 10.1038/srep27156

Walther E, Xu Z, Richter M, Kirchmair J, Grienke U , Rollinger JM et al. Dual acting neuraminidase inhibitors open new opportunities to disrupt the lethal synergism between Streptococcus pneumoniae and influenza virus. Frontiers in Microbiology. 2016 Mar 21;7:357. doi: 10.3389/fmicb.2016.00357

Waltenberger B, Atanasov AG, Heiss EH, Bernhard D, Rollinger JM, Breuss JM et al. Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project. Monatshefte für Chemie. 2016 Mar;147(3):479-491. doi: 10.1007/s00706-015-1653-y

Grienke U, Richter M, Walther E, Hoffmann A, Kirchmair J, Makarov V et al. Killing two birds with one stone - Prenylated flavonoids disrupt the lethal synergism of influenza A viruses and pneumococci. Planta Medica. 2016;81(S01):S1-S381. doi: 10.1055/s-0036-1596116

Grienke U, Mair CE, Saxena P, Baburin I, Scheel O, Ganzera M et al.. hERG channel inhibiting alkaloids from Nelumbo nucifera: How safe is the “Lotus Leaf Diet”?. 2015. 24. Wissenschaftliche Tagung der ÖPhG, Wien, Austria.

Mair CE, Silva CM, Grienke U, Carreño F, Kratz JM, Dalla Costa T et al.. In vivo characterisation of voacangine - a hERG blocking iboga alkaloid from Voacanga africana. 2015. 24. Wissenschaftliche Tagung der ÖPhG, Wien, Austria.

Atanasov A, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnology Advances. 2015 Aug 15;33(8):1582-1614. doi: 10.1016/j.biotechadv.2015.08.001

Mair CE, Liu R, Atanasov AG, Wimmer L, Nemetz-Fiedler D, Sider N et al. Piperine Congeners as Inhibitors of Vascular Smooth Muscle Cell Proliferation. Planta Medica: natural products and medicinal plant research. 2015 Aug;81(12-13):1065-1074. doi: 10.1055/s-0035-1546165

Grienke U, Mair CE, Saxena P, Baburin I, Scheel O, Ganzera M et al. Human Ether-à-go-go Related Gene (hERG) Channel Blocking Aporphine Alkaloids from Lotus Leaves and Their Quantitative Analysis in Dietary Weight Loss Supplements. Journal of Agricultural and Food Chemistry. 2015 Jun 17;63(23):5634-5639. doi: 10.1021/acs.jafc.5b01901

Grienke U, Kaserer T, Pfluger F, Mair CE, Langer T, Schuster D et al. Accessing biological actions of Ganoderma secondary metabolites by in silico profiling. Phytochemistry. 2015 Jun;114:114-124. doi: 10.1016/j.phytochem.2014.10.010

Walther E, Richter M, Xu Z, Kramer C, von Grafenstein S, Kirchmair J et al. Antipneumococcal activity of neuraminidase inhibiting artocarpin. International Journal of Medical Microbiology. 2015 May;305(3):289-297. doi: 10.1016/j.ijmm.2014.12.004

Rollinger JM, Quinn RJ. In silico Driven Pharmacognosy: Forth, Back and Reverse. Planta Medica: natural products and medicinal plant research. 2015 Apr;81(6):427-428. doi: 10.1055/s-0035-1545940

Vuorinen A, Seibert J, Papageorgiou VP, Rollinger JM, Odermatt A, Schuster D et al. Pistacia lentiscus Oleoresin: Virtual screening and identification of masticadienonic and isomasticadienonic acids as inhibitors of 11 β -hydroxysteroid dehydrogenase 1. Planta Medica: natural products and medicinal plant research. 2015 Apr;81(6):525-532. doi: 10.1055/s-0035-1545720

Richter M, Schumann L, Walther E, Hoffmann A, Braun H, Grienke U et al. Complementary assays helping to overcome challenges for identifying neuraminidase inhibitors. Future Virology. 2015 Feb 1;10(2):77-88. doi: 10.2217/FVL.14.97

Dresch P, D'Aguanno MN, Rosam K, Grienke U , Rollinger JM, Peintner U. Fungal strain matters: colony growth and bioactivity of the European medicinal polypores Fomes fomentarius, Fomitopsis pinicola and Piptoporus betulinus. AMB Express. 2015 Jan 24;5(1):4. doi: 10.1186/s13568-014-0093-0

von Grafenstein S, Wallnoefer HG, Kirchmair J, Fuchs JE, Huber RG, Schmidtke M et al. Interface dynamics explain assembly dependency of influenza neuraminidase catalytic activity. Journal of biomolecular structure & dynamics. 2015 Jan 2;33(1):104-120. doi: 10.1080/07391102.2013.855142

Grienke U, Kaserer T, Pfluger F, Mair CE, Schmidtke M, Langer T et al. In silico pharmacological profiling of Ganoderma secondary metabolites to unravel the polypharmacological nature of Reishi. Planta Medica: natural products and medicinal plant research. 2015;81.

Mair CE, Silva CM, Grienke U, Carreño F, Müller Kratz J, Dalla Costa T et al. Pre-clinical pharmacokinetics of the hERG blocking iboga alkaloid voacangine from Voacanga africana. Planta Medica: natural products and medicinal plant research. 2015;81.

Picker P, Vogl S, McKinnon R, Mihaly-Bison J, Binder M, Atanasov AG et al. Plant extracts in cell-based anti-inflammatory assays - Pitfalls and considerations related to removal of activity masking bulk components. Phytochemistry Letters. 2014 Dec;10:xli-xlvii. Epub 2014 Apr 18. doi: 10.1016/j.phytol.2014.04.001

Wang L, Waltenberger B, Pferschy-Wenzig EM, Blunder M, Liu X, Malainer C et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochemical Pharmacology. 2014 Nov 1;92(1):73-89. doi: 10.1016/j.bcp.2014.07.018

The potential of polypore extracts to modulate angiogenesis and inflammation: Insights from in vitro screening on endothelial cell proliferation, migration, and leukocyte recruitment

Achenbach, J. (Contributor), Wasilewicz, A. (Contributor), Roggio, A. (Contributor), Grienke, U. (Contributor), Beniddir, M. A. (Contributor), Rollinger, J. M. (Contributor), Fürst, R. (Contributor) & Kirchweger, B. (Speaker)

3 Sept 2025